Compare TC & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TC | PROF |
|---|---|---|
| Founded | 2010 | N/A |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.8M | 244.6M |
| IPO Year | 2018 | 2017 |
| Metric | TC | PROF |
|---|---|---|
| Price | $1.55 | $6.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 9.7K | ★ 53.1K |
| Earning Date | 03-28-2025 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.89 |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $16,098,000.00 |
| Revenue This Year | N/A | $92.40 |
| Revenue Next Year | N/A | $64.10 |
| P/E Ratio | ★ N/A | $34.68 |
| Revenue Growth | N/A | ★ 50.73 |
| 52 Week Low | $0.53 | $3.92 |
| 52 Week High | $19.99 | $8.95 |
| Indicator | TC | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 13.07 | 50.09 |
| Support Level | $0.53 | $6.47 |
| Resistance Level | $11.40 | $7.06 |
| Average True Range (ATR) | 1.06 | 0.30 |
| MACD | -0.53 | -0.00 |
| Stochastic Oscillator | 0.98 | 52.94 |
Token Cat Ltd has two reportable business segments: automotive electronics resale business and advertising business. The automotive electronics resale business focuses on sourcing, holding, and reselling automotive electronics products, and includes sales of automotive electronic component equipment and accessories, mainly consisting of communication device and power module. The Company procures products from third-party suppliers and resells them to customers through its sales channels. The advertising business currently consists mainly of proxy advertising services, through which the Company helps clients promote their brands, services and products on third-party online platforms. The automotive electronics resale business segment generates maximum revenue.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.